Evidence map›Paper›PMID 28443673›Full record

ReviewAntioxidants & redox signaling2017

Fluorescent Probes and Selective Inhibitors for Biological Studies of Hydrogen Sulfide- and Polysulfide-Mediated Signaling.

Yoko Takano, Honami Echizen, Kenjiro Hanaoka

Open access · hybridAbstract readReview
In one paragraph

Review in Antioxidants & redox signaling, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
4.5field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 58 citations in OpenAlex.

  1. Review
  2. Article
  3. HFrontiers in cell and developmental biology · 2026
    Review
  4. Review
  5. Article
  6. Review
  7. Sulfur Administration in Fe-S Cluster Homeostasis.Antioxidants (Basel, Switzerland) · 2021
    Review
  8. Accessing lanthanide-based,Chemical science · 2021
    Article
  9. The Hidden Role of Hydrogen Sulfide Metabolism in Cancer.International journal of molecular sciences · 2021
    Review
  10. HThe Journal of biological chemistry · 2020
    Review
  11. Review
  12. Exogenous HAging and disease · 2020
    Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Endogenous HBMC cancer · 2018
    Article
  18. The Drug Developments of Hydrogen Sulfide on Cardiovascular Disease.Oxidative medicine and cellular longevity · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Yoko TakanoGraduate School of Pharmaceutical Sciences, The University of Tokyo , Tokyo, Japan .
Honami EchizenGraduate School of Pharmaceutical Sciences, The University of Tokyo , Tokyo, Japan .
Kenjiro HanaokaGraduate School of Pharmaceutical Sciences, The University of Tokyo , Tokyo, Japan .
The University of Tokyo · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

significanceHydrogen sulfide (H CRITICAL ISSUES: In this review, we summarize recent progress in developing chemical tools for the study of H FUTURE DIRECTIONS: Despite recent progress, the precise biological functions of H

Indexed as

AnimalsCystathionine beta-SynthaseCystathionine gamma-LyaseEnzyme InhibitorsFluorescent DyesGene Regulatory NetworksHumansHydrogen SulfideSignal TransductionSulfidesSulfurtransferases3-mercaptopyruvate sulphurtransferaseCystathionine beta-SynthaseCystathionine gamma-LyaseEnzyme InhibitorsFluorescent DyesHydrogen SulfidepolysulfideSulfidesSulfurtransferasesfluorescence imaginginhibitorsreactive sulfur species

Identifiers

PMID28443673
PMCPMC5576268
OpenAlexW2607697691

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.